ExLibris header image
SFX Logo
Title: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
Source:

Scientific Reports [2045-2322] yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Izzo, Nicholas J. "Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits." PLoS ONE 9.11 (2014). Link to Full Text for this item Link to SFX for this item
2. "10 early signs and symptoms of Alzheimer's." Retirement Advisor 15.11 (2014): 17-. Link to SFX for this item
3. Lee, L. "Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease." Scientific Reports 5 (2015): 11782-. Link to Full Text for this item Link to SFX for this item
4. Dawkins, E. "Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease." Journal of neurochemistry 129.5 (2014): 756-769. Link to Full Text for this item Link to SFX for this item
5. Wirth, M. "Associations Between Alzheimer Disease Biomarkers, Neurodegeneration, and Cognition in Cognitively Normal Older People." JAMA neurology 70.12 (2013): 1512-1519. Link to SFX for this item
6. Catalano, Susan M. "Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity." PLoS ONE 9.11 (2014): 1-15. Link to Full Text for this item Link to SFX for this item
7. Tang, J. "Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease." Acta Biochimica et Biophysica Sinica 45.8 (2013): 613-621. Link to Full Text for this item Link to SFX for this item
8. Wirth, M. "Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals." The Journal of neuroscience 33.13 (2013): 5553-5563. Link to Full Text for this item Link to SFX for this item
9. Writers, S. "Promising compound restores memory loss and reverses symptoms of Alzheimer's." Space daily (2013). Link to SFX for this item
10. Fa, M. "Dynamin 1 Is Required for Memory Formation." PLoS ONE 9.3 (2014). Link to Full Text for this item Link to SFX for this item
11. Nourhashémi, F. "Facteurs associés au stade modérément sévère de la maladie d'Alzheimer : premiers résultats de l'étude REAL.FR." La Revue de médecine interne 24 (2003): 339-344. Link to SFX for this item
12. Li, M. "Stem Cell Treatment for Alzheimer's Disease." International journal of molecular sciences 15.10 (2014): 19226-19238. Link to Full Text for this item Link to SFX for this item
13. Yan, R. "Targeting the β secretase BACE1 for Alzheimer's disease therapy." Lancet neurology 13.3 (2014): 319-329. Link to SFX for this item
14. Obulesu, M. "Neuroinflammation in Alzheimer's Disease: An understanding of physiology and pathology." International journal of neuroscience 124.4 (2013): 227-35. Link to SFX for this item
15. Wirth, M. "The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly." Alzheimer's & dementia 9.6 (2013): 687-6980. Link to SFX for this item
16. Marchant, Natalie L. "The Aging Brain and Cognition: Contribution of Vascular Injury and Aβ to Mild Cognitive Dysfunction." JAMA neurology 70.4 (2013): 1-8. Link to SFX for this item
17. La Joie, R. "Region-Specific Hierarchy between Atrophy, Hypometabolism, and beta-Amyloid (A beta) Load in Alzheimer's Disease Dementia." The Journal of neuroscience 32.46 (2012): 16265-16273. Link to Full Text for this item Link to SFX for this item
18. Leuba G, Walzer C, Vernay A, Carnal B, Kraftsik R,, G. "Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction." Neurobiology of disease 30.3 (2008): 408-19. Link to SFX for this item
19. Cheon, M. S. S. "Protein expression of BACE1, BACE2 and APP in Down syndrome brains." Amino acids 35.2 (2008): 339-343. Link to SFX for this item
20. Cirrito, John R R. "Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo." Neuron 58.1 (2008): 42-51. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.